Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cross-reactivity00:42

Cross-reactivity

Overview
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma.

The journal of allergy and clinical immunology. Global·2026
Same author

Baseline blood eosinophil count does not predict short-term changes in oscillometric psarameters in steroid-naïve asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Black eye without a blow: eyelid ecchymosis triggered by coughing.

Oxford medical case reports·2025
Same author

Case Report: Sequential use of tezepelumab and mepolizumab for eosinophilic otitis media in EGPA: a steroid-sparing strategy.

Frontiers in allergy·2025
Same author

Biomarker-guided IL-5 blockade achieves steroid-free MPO-ANCA seroconversion in EGPA.

The journal of allergy and clinical immunology. Global·2025
Same author

Clinical and pathophysiological roles of lower lobe-dominant mucus plugs on computed tomography in patients with asthma with and without bronchiectasis.

The journal of allergy and clinical immunology. Global·2025

Related Experiment Video

Updated: Jul 2, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

ADAM8 in allergy.

Osamu Matsuno1, Toshihide Kumamoto, Yasunori Higuchi

  • 1Division of Respiraory Disease, Osaka Minami Medical Center, Kawachinagano-City, Osaka, Japan. matsuno@med.oita-u.ac.jp

Inflammation & Allergy Drug Targets
|August 12, 2008
PubMed
Summary

ADAM8, a protein involved in immune responses, plays a key role in allergic inflammation and asthma. Targeting ADAM8 offers a promising therapeutic strategy for allergic respiratory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Respiratory Medicine

Background:

  • ADAM (a disintegrin and metalloprotease) proteins are crucial for various cellular functions, including cell adhesion and signaling.
  • ADAM8 (CD156a) is predominantly expressed in immune cells and functions as a sheddase for specific cell surface molecules.
  • ADAM8 is implicated in the pathogenesis of allergic inflammation and respiratory diseases like asthma.

Purpose of the Study:

  • To review the role of ADAM8 in allergic respiratory diseases.
  • To discuss novel immune intervention strategies targeting ADAM8 for therapeutic purposes.

Main Methods:

  • Review of existing literature on ADAM8 function and its role in allergic inflammation.
  • Analysis of ADAM8 expression patterns in disease progression and experimental models.

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

Related Experiment Videos

Last Updated: Jul 2, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

  • Examination of ADAM8's substrate cleavage and its physiological impact.
  • Main Results:

    • ADAM8 expression is elevated in asthma and experimental allergic lung disease.
    • ADAM8 acts as a sheddase for CD23 and L-selectin, contributing to allergic inflammation.
    • Soluble ADAM8 levels are increased in patients with eosinophilic pneumonia.
    • ADAM8 exhibits a protective role against allergic pulmonary disease in murine models.

    Conclusions:

    • ADAM8 is a significant mediator of allergic respiratory diseases.
    • Targeting ADAM8 presents a potential therapeutic avenue for allergic respiratory conditions.
    • Novel immune intervention strategies focusing on ADAM8 are under investigation.